Takeda Pharmaceutical Co. (NYSE:TAK – Get Free Report) shares reached a new 52-week high during trading on Monday . Weiss Ratings reissued a “hold (c-)” rating on shares of Takeda Pharmaceutical in a report on Monday, December 29th. Get Takeda Pharmaceutical alerts:Check Out Our Latest Analysis on Takeda PharmaceuticalTakeda Pharmaceutical Stock PerformanceThe company has a market cap of $53.07 billion, a PE ratio of 208.48 and a beta of 0.03. Takeda Pharmaceutical (NYSE:TAK – Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. Recommended StoriesReceive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.